INO Inovio Pharmaceuticals, Inc.

Fundamentals / CIK 0001055726 / USD

Inovio Pharmaceuticals, Inc. reported $299K in revenue and a net loss of $71.14M for the trailing twelve months ended September 30, 2026 (down 70.0% year over year), with a -25953.8% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open INO in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

10 fiscal years (2016 to 2025), reported in USD.

$73.68M$36.84M$0-$287.5MFY 2016 Revenue: $35.37MFY 2016 Net Income: -$73.74M2016FY 2017 Revenue: $42.22MFY 2017 Net Income: -$88.21M2017FY 2018 Revenue: $30.48MFY 2018 Net Income: -$96.97M2018FY 2019 Revenue: $4.11MFY 2019 Net Income: -$119.4M2019FY 2020 Revenue: $7.41MFY 2020 Net Income: -$166.4M2020FY 2021 Revenue: $1.77MFY 2021 Net Income: -$303.7M2021FY 2022 Revenue: $10.26MFY 2022 Net Income: -$279.8M2022FY 2023 Revenue: $832KFY 2023 Net Income: -$135.1M2023FY 2024 Revenue: $218KFY 2024 Net Income: -$107.3M2024FY 2025 Revenue: $65KFY 2025 Net Income: -$84.95M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue $65K $218K $832K $10.26M $1.77M $7.41M $4.11M $30.48M $42.22M $35.37M
Research & Development $54.21M $75.62M $86.68M $187.7M $249.2M $94.25M $88.02M $95.26M $98.57M $88.71M
Total Operating Expenses $86.89M $112.6M $144.8M $277.8M $303.0M $131.5M $115.2M $124.6M $125.9M $111.6M
Operating Income -$86.82M -$112.4M -$143.9M -$267.6M -$301.2M -$124.1M -$111.1M -$94.09M -$83.64M -$76.24M
EBITDA -$85.40M -$110.6M -$141.2M -$263.4M -$297.7M -$120.5M -$106.4M -$89.09M -$80.17M -$73.15M
Interest Income $2.42M $4.77M $8.13M $4.78M $3.36M $3.31M $2.61M $2.26M $1.84M --
Interest Expense $0 $178K $1.22M $1.25M $1.94M $8.70M $7.95M $0 $26K --
Income Before Tax -$84.95M -$107.3M -$135.1M -$277.7M -$303.2M -$162.9M -$120.8M -$94.80M -$88.21M -$73.74M
Income Tax Expense $0 $0 $0 $0 $0 $0 -$257K $2.17M $0 $0
Net Income -$84.95M -$107.3M -$135.1M -$279.8M -$303.7M -$166.4M -$119.4M -$96.97M -$88.21M -$73.74M
Basic EPS -$1.81 -$3.95 -$6.09 -$14.07 -$17.45 -$12.85 -$14.53 -$12.61 -$12.97 -$12.12
Diluted EPS -$1.81 -$3.95 -$6.09 -$14.07 -$17.45 -$12.85 -$14.53 -$12.61 -$13.09 -$12.12
Basic Shares Outstanding 46.9M 27.2M 22.2M 19.9M 17.4M 12.9M 8.2M 7.7M 6.8M 6.1M
Diluted Shares Outstanding 46.9M 27.2M 22.2M 19.9M 17.4M 12.9M 8.2M 7.7M 6.8M 6.1M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue $299K $0 $0 $0 $0 $0 $65K $117K
Research & Development $10.62M $10.83M $14.07M $10.26M $13.33M $14.52M $16.09M $12.89M
Total Operating Expenses $19.82M $18.62M $21.95M $17.48M $21.21M $23.08M $25.12M $20.49M
Operating Income -$19.52M -$18.62M -$21.95M -$17.48M -$21.21M -$23.08M -$25.05M -$20.37M
EBITDA -$19.20M -$18.30M -$21.63M -$17.14M -$20.86M -$22.73M -$24.68M -$19.95M
Interest Income $356K $364K $440K $449K $552K $611K $808K $853K
Interest Expense -- -- -- $0 $0 $0 $0 $0
Net Income -$49.20M -$6.01M -$19.68M $3.76M -$45.50M -$23.52M -$19.69M -$19.38M
Basic EPS -$0.50 -$0.07 -$0.28 -- -$0.87 -$0.61 -$0.51 --
Diluted EPS -$0.50 -$0.07 -$0.28 -- -$0.87 -$0.61 -$0.51 --
Basic Shares Outstanding 98.6M 81.6M 69.1M -- 52.2M 38.8M 38.6M --
Diluted Shares Outstanding 98.6M 81.6M 69.1M -- 52.2M 38.8M 38.6M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $44.27M $65.81M $14.31M $46.33M $71.14M $250.7M $22.20M $23.69M $23.79M $19.14M
Short-Term Investments $14.24M $28.30M $131.0M $206.7M $330.2M $160.9M $67.34M $57.54M $103.6M $85.63M
Cash & Short-Term Investments $58.50M $94.10M $145.3M $253.0M $401.3M $411.6M $89.50M $81.20M $127.4M $104.8M
Accounts Receivable, Net $450 $1.20M $2.41M $1.70M $5.47M $18.56M $700K $3.32M $6.00M $15.82M
Total Current Assets $61.12M $97.83M $153.1M $315.2M $448.4M $471.2M $94.20M $87.81M $138.4M $124.6M
Property, Plant & Equipment, Net $2.53M $3.66M $4.96M $7.73M $17.45M $11.35M $12.77M $15.95M $18.32M $9.03M
Goodwill -- -- $0 $10.51M $10.51M $10.51M $10.51M $10.51M $10.51M $10.51M
Intangible Assets -- -- $0 $2.13M $2.63M $3.15M $3.69M $4.76M $6.01M $7.63M
Long-Term Investments -- -- -- -- -- -- -- $9.40M -- --
Other Non-Current Assets $2.01M $1.98M $605K $684K $1.43M $25.96M $2.67M $2.67M $2.64M $2.11M
Total Non-Current Assets $13.19M $15.37M $17.84M $33.29M $47.50M $68.60M $49.75M $43.30M $48.88M $49.11M
Total Assets $74.31M $113.2M $171.0M $348.5M $495.9M $539.8M $144.0M $131.1M $187.2M $173.7M
Deferred Revenue (Current) $0 -- -- $0 $22K $47K $92K $224K $1.18M $14.76M
Other Current Liabilities -- -- -- -- -- -- -- -- $0 --
Total Current Liabilities $43.67M $35.33M $42.57M $96.87M $65.74M $41.71M $31.99M $35.30M $35.41M $43.82M
Long-Term Debt -- -- -- -- -- -- -- $0 -- --
Deferred Revenue (Non-Current) -- -- -- $0 $64K $79K $102K $151K $216K $318K
Other Non-Current Liabilities -- -- -- $0 $15K $58K $37K $87K $0 --
Total Non-Current Liabilities $6.55M $9.37M $11.03M $29.30M $30.53M $36.93M $106.6M $8.78M $9.35M $6.51M
Total Liabilities $50.21M $44.69M $53.60M $126.2M $96.27M $78.63M $138.5M $44.08M $44.75M $50.33M
Total Debt (incl. Leases) $9.37M $11.87M $13.44M $15.46M $18.06M $20.39M $22.48M $0 -- --
Common Stock $69K $36K $23K $21K $217K $187K $101K $97K $90K $74K
Retained Earnings -$1.82B -$1.73B -$1.62B -$1.49B -$1.21B -$906.2M -$739.8M -$620.4M -$523.4M -$434.8M
Accumulated Other Comp. Income -$638K -$676K -$663K -$699K -$282K -$256K $473K -$529K -$117K $1.33M
Total Stockholders' Equity $24.10M $68.50M $117.3M $222.4M $399.7M $461.1M $3.44M $86.94M $142.4M $123.3M
Total Equity $24.10M $68.50M $117.3M $222.4M $399.7M $461.1M $5.40M $87.03M $142.5M $123.4M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $46.96M $31.53M $26.27M $44.27M $36.57M $24.35M $39.92M $65.81M
Short-Term Investments $1.40M $5.15M $11.41M $14.24M $14.24M $23.20M $28.45M $28.30M
Cash & Short-Term Investments $48.40M $36.70M $37.70M $58.50M $50.80M $47.50M $68.40M $94.10M
Accounts Receivable, Net -- -- -- $450 $979K $840K $1.31M $1.20M
Total Current Assets $51.44M $39.91M $39.44M $61.12M $55.18M $52.70M $71.89M $97.83M
Property, Plant & Equipment, Net $1.57M $1.89M $2.21M $2.53M $2.74M $3.09M $3.35M $3.66M
Other Non-Current Assets $1.92M $1.92M $2.01M $2.01M $2.01M $2.01M $1.98M $1.98M
Total Non-Current Assets $8.69M $9.48M $10.34M $13.19M $14.21M $15.54M $15.38M $15.37M
Total Assets $60.14M $49.39M $49.78M $74.31M $69.39M $68.24M $87.27M $113.2M
Deferred Revenue (Current) $652K -- -- $0 -- -- -- --
Total Current Liabilities $89.47M $39.92M $37.92M $43.67M $69.82M $31.71M $27.33M $35.33M
Total Non-Current Liabilities $4.59M $5.10M $5.79M $6.55M $7.28M $8.00M $8.70M $9.37M
Total Liabilities $94.06M $45.02M $43.71M $50.21M $77.11M $39.71M $36.02M $44.69M
Total Debt (incl. Leases) $7.28M $8.00M $8.70M $9.37M $10.02M $10.66M $11.27M $11.87M
Common Stock $110K $82K $70K $69K $54K $37K $37K $36K
Retained Earnings -$1.89B -$1.84B -$1.83B -$1.82B -$1.82B -$1.77B -$1.75B -$1.73B
Accumulated Other Comp. Income -$267K -$280K -$636K -$638K -$647K -$662K -$661K -$676K
Total Stockholders' Equity -$33.92M $4.37M $6.07M $24.10M -$7.72M $28.53M $51.25M $68.50M
Total Equity -$33.92M $4.37M $6.07M $24.10M -$7.72M $28.53M $51.25M $68.50M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$84.95M -$107.3M -$135.1M -$279.8M -$303.7M -$167.5M -$120.6M -$96.97M -$88.21M -$73.74M
Depreciation & Amortization $1.42M $1.75M $2.77M $4.15M $3.56M $3.59M $4.66M $5.00M $3.47M $3.09M
Stock-Based Compensation $3.76M $6.60M $11.07M $22.56M $26.34M $15.65M $10.90M $10.65M $13.07M $10.48M
Change in Receivables -- $1.21M $9.33M -$3.71M $11.03M -$17.02M $2.62M $2.69M $9.82M -$8.52M
Operating Cash Flow -$88.63M -$104.1M -$124.4M -$216.2M -$215.7M -$178.0M -$97.85M -$73.55M -$63.21M -$62.56M
Capital Expenditure -$286K -$488K -$321K -$969K -$1.23M -$1.52M -$988K -$2.09M -$10.29M -$2.74M
Free Cash Flow -$88.92M -$104.6M -$124.7M -$217.2M -$216.9M -$179.5M -$98.84M -$75.64M -$73.50M -$65.29M
Investing Cash Flow $14.04M $104.1M $87.36M $109.6M -$175.3M -$58.80M -$9.04M $42.42M -$27.83M $16.27M
Common Stock Issued $34.91M $36.03M $5.46M $82.96M $209.4M $454.5M $9.09M $29.23M $94.35M $6.30M
Financing Cash Flow $53.05M $51.48M $5.00M $81.84M $211.5M $465.3M $105.4M $31.04M $95.69M $7.79M
Net Change in Cash -$21.54M $51.50M -$32.02M -$24.81M -$179.6M $228.5M -$1.50M -$93K $4.65M -$38.50M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$49.20M -$6.01M -$19.68M $3.76M -$45.50M -$23.52M -$19.69M -$19.38M
Depreciation & Amortization $322K $322K $317K $340K $350K $356K $371K $417K
Stock-Based Compensation $868K $768K $699K $765K $757K $835K $1.40M $1.32M
Change in Receivables -- -- -- -- -$138K $470K -$111K $664K
Operating Cash Flow -$15.27M -$18.05M -$21.59M -$19.37M -$21.57M -$20.81M -$26.87M -$19.66M
Capital Expenditure $0 $0 $0 -$127K -$68K -$31K -$59K $0
Free Cash Flow -$15.27M -$18.05M -$21.59M -$19.50M -$21.64M -$20.84M -$26.93M -$19.66M
Investing Cash Flow $3.72M $6.15M $2.64M -$58K $8.87M $5.28M -$52K $34.64M
Common Stock Issued $3.01M $3.25M $1.08M $26.62M $7.19M $0 $1.10M $13.08M
Financing Cash Flow $26.99M $17.16M $954K $27.13M $24.92M -$35K $1.03M $29.15M
Net Change in Cash $15.44M $5.25M -$18.00M $7.71M $12.22M -$15.56M -$25.90M $44.13M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Operating Margin -132871.3% -51616.9% -17300.3% -2607.4% -16972.3% -1674.2% -2702.1% -308.7% -198.1% -215.5%
Net Profit Margin -130000.0% -49254.3% -16239.9% -2726.7% -17109.9% -2245.4% -2902.8% -318.1% -208.9% -208.5%
Return on Equity (ROE) -352.5% -156.6% -115.1% -125.8% -76.0% -36.1% -3474.7% -111.5% -61.9% -59.8%
Return on Assets (ROA) -114.3% -94.7% -79.0% -80.3% -61.2% -30.8% -82.9% -74.0% -47.1% -42.5%
Current Ratio 1.40x 2.77x 3.60x 3.25x 6.82x 11.30x 2.94x 2.49x 3.91x 2.84x
Quick Ratio 1.34x 2.70x 3.47x 2.63x 6.19x 10.31x 2.82x 2.39x 3.77x 2.75x
Debt to Equity 0.39x 0.17x 0.11x 0.07x 0.05x 0.04x 6.55x 0.00x -- --
Revenue Growth (YoY) -70.0% -73.8% -91.9% +478.2% -76.1% +80.2% -86.5% -27.8% +19.4% -12.8%
5Y Revenue / Share Growth -99.8% -98.4% -99.1% -91.7% -98.2% -92.0% -76.4% +12.7% +327.8% +55.6%
10Y Revenue / Share Growth -100.0% -99.6% -98.9% -64.4% -97.3% -79.9% -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Operating Margin -25953.8% -- -- -132871.3% -49202.9% -52568.6% -37430.2% -51616.9%
Net Profit Margin -23798.9% -- -- -130000.0% -59281.7% -48131.4% -34079.6% -49254.3%
Return on Equity (ROE) -- -1542.6% -1399.7% -352.5% -- -307.6% -188.2% -156.6%
Return on Assets (ROA) -118.3% -136.5% -170.6% -114.3% -155.8% -128.6% -110.5% -94.7%
Current Ratio 0.57x 1.00x 1.04x 1.40x 0.79x 1.66x 2.63x 2.77x
Quick Ratio 0.54x 0.92x 0.99x 1.34x 0.74x 1.52x 2.55x 2.70x
Debt to Equity -- 1.83x 1.43x 0.39x -- 0.37x 0.22x 0.17x
Revenue Growth (YoY) -- -- -100.0% -100.0% -- -100.0% -- +14.0%
Source: SEC EDGAR CompanyFacts (CIK 0001055726) · from December 31, 2009 Data through September 30, 2026 · synced Nov 20, 2026, 05:49 UTC · Open in terminal